Key findings Across all four trials, GLP-1 RAs were consistently associated with lower rates of alcohol-related hospitalization within one year in balanced populations: ADM trial (n = 18,515) : Alcohol-related hospitalization occurred in 10.1% of newer GLP-1 RA users vs
J Endocrinol2007 May;193(2):259-67
"Obesity is a key therapeutic area for Pfizer, and the company has a robust pipeline of three clinical and several pre-clinical candidates
Clinically, these reductions in physiological drive may provide a window of opportunity in which behavioral strategies such as stimulus control, self-monitoring, and structured eating routines may be adopted more consistently
3-Part Series Answering Your Most Commonly Asked Questions Regarding GLP-1 Medications Dec 12, 2024 Part 2: What are the common side effects of these medications
Within seconds of the sensing of increased reactive oxygen species (ROS), several enzymes of glycolysis (particularly glyceraldehyde-3-phosphate dehydrogenase and pyruvate kinase) are inhibiting allowing for the diversion of glucose carbons into the PPP